Improved synthetic method of Benzo[a]pheno-selenazinium phototherapeutic agents
Source abstract
Abstract
Abstract Benzo[a]phenoselenazinium dyes are excellent photodynamic therapeutic agents that have a red absorption (660 nm), high singlet oxygen quantum yield (>0.8), and good water-solubility and liposolubility. Bis-(3-diethylaminophenyl) diselenide, the most important intermediate for the synthesis of benzo[a]phenoselenazinium dyes, is previously prepared in one pot through 3 steps, during which special care is needed for the preparation of Grinard reagent and toxic selenium vapor. In this work, we employed CuO nanopowder to directly couple haloaniline with selenium to obtain pure bis-(3-diethylaminophenyl) diselenide (one step) under a mild condition with a high reaction yield without the need of column chromatography. Four benzo[a]phenoselenazinium dyes, 5a-d, were easily prepared using the improved synthesis method; and their phototoxicity in living cells were investigated. The improved method could be employed in large-scale synthesis of benzo[a]phenoselenazinium dyes, thereby may stimulate the photodynamic study of this type of photosensitizer.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Porphyrin and Phthalocyanine Chemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (36)
Show source-provided references
1. GSH-triggered release of sulfur dioxide gas to regulate redox balance for enhanced photodynamic therapy10.1039/D0CC00470G ↗
2. Chemiluminescence as a PDT light source for microbial control10.1016/j.jphotobiol.2011.01.018 ↗
3. Stimuli-responsive reversible switching of intersystem crossing in pure organic material for smart photodynamic therapy10.1002/anie.201905129 ↗
4. Enhanced photodynamic therapy and fluorescence imaging using gold nanorods for porphyrin delivery in a novel in vitro squamous cell carcinoma 3D model10.1039/D0TB00810A ↗
5. PDT dose parameters impact tumoricidal durability and cell death pathways in a 3D ovarian cancer model10.1111/php.12065 ↗
6. HIV infection of CD8 lymphocytes: a critical step for the disease?
7. Photosensitized destruction of human bladder carcinoma cells treated with chlorin e6-conjugated microspheres10.1073/pnas.88.4.1580 ↗
8. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization10.1021/cr900300p ↗
9. Activatable photosensitizers for imaging and therapy10.1021/cr900236h ↗
10. Near-infrared light-initiated molecular superoxide radical generator: rejuvenating photodynamic therapy against hypoxic tumors10.1021/jacs.8b08658 ↗
11. Superoxide radical photogenerator with amplification effect: surmounting the achilles' heels of photodynamic oncotherapy10.1021/jacs.8b13141 ↗
12. Organic photodynamic nanoinhibitor for synergistic cancer therapy10.1002/anie.201903968 ↗
13. Membrane-anchoring photosensitizer with aggregation-induced emission characteristics for combating multidrug-resistant bacteria10.1002/anie.201907343 ↗
14. A semiconducting polymer nano-prodrug for hypoxia-activated photodynamic cancer therapy10.1002/anie.201814730 ↗
15. Photosensitization of biomolecules by phenothiazine derivatives10.2174/138945006778226561 ↗
16. Antimicrobial efficacy of photodynamic therapy and light-activated disinfection on contaminated zirconia implants: an in vitro study10.1016/j.pdpdt.2018.01.017 ↗
17. Photodynamic therapy and anti-tumour immunity10.1038/nrc1894 ↗
18. Two-photon excitation nanoparticles for photodynamic therapy10.1039/C6CS00442C ↗
19. Photodynamic therapy and anti-tumour immunity10.1038/nrc1894 ↗
20. Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death10.1016/S1572-1000(05)00030-X ↗
21. Exploiting a bacterial drug-resistance mechanism: a light-activated construct for the destruction of MRSA10.1002/anie.200804804 ↗
22. Real-time fluorescence monitoring of phenothiazinium photosensitizers and their anti-mycobacterial photodynamic activity against Mycobacterium bovis BCG in in vitro and in vivo models of localized infection10.1039/b707962a ↗
23. Factors affecting virus photoinactivation by a series of phenothiazine dyes10.1111/j.1751-1097.1998.tb05208.x ↗
24. The role of photosensitizer molecular charge and structure on the efficacy of photodynamic therapy against Leishmania parasites10.1016/j.chembiol.2006.06.008 ↗
25. Synthesis and properties of benzo[a]phenoxazinium chalcogen analogues as novel broad-spectrum antimicrobial photosensitizers10.1021/jm060153i ↗
26. Structure-function relationships of Nile blue (EtNBS) derivatives as antimicrobial photosensitizers10.1016/j.ejmech.2014.01.064 ↗
27. EtNBSe-PDT inhibited proliferation and induced autophagy of HNE-1 cells via downregulating the Wnt/beta-catenin signaling pathway10.1016/j.pdpdt.2019.02.024 ↗
28. Endoplasmic reticulum stress-mediated autophagy contributes to 5-ethylamino-9-diethylaminobenzo[a]phenoselenazinium-mediated photodynamic therapy via the PERK-eIF2α pathway10.2147/OTT.S163366 ↗
29. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug
30. Photodynamic therapy for cutaneous leishmaniasis: the effectiveness of topical phenothiaziniums in parasite eradication and Th1 immune response stimulation10.1039/b703521g ↗
31. Benzophenothiazine and benzoporphyrin derivative combination phototherapy effectively eradicates large murine sarcomas10.1111/j.1751-1097.1996.tb03019.x ↗
32. Novel red absorbing benzo[a]phenoxazinium and benzo[a]phenothiazinium photosensitizers: in vitro evaluation10.1111/j.1751-1097.1987.tb04843.x ↗
33. Synthesis of short and long-wavelength functionalised probes: amino acids' labelling and photophysical studies10.1016/j.tet.2007.09.042 ↗
34. Chalcogenapyrylium dyes as potential photochemotherapeutic agents. Solution studies of heavy atom effects on triplet yields, quantum efficiencies of singlet oxygen generation, rates of reaction with singlet oxygen, and emission quantum yields10.1021/ja00166a019 ↗
35. Heteroatom substitution induced changes in excited-state photophysics and singlet oxygen generation in chalcogenoxanthylium dyes: effect of sulfur and selenium substitutions10.1021/jp0370674 ↗
36. Development of an azo-based photosensitizer activated under mild hypoxia for photodynamic therapy10.1021/jacs.7b05019 ↗